Skip to main content
. 2020 Mar 16;7(4):ofaa090. doi: 10.1093/ofid/ofaa090

Table 4.

Outcomes

Treatment Group Linezolid- Containing (n = 20), No. (%) Non-Linezolid- Containing (n = 8), No. (%) P Value
Cure 17 (85) 6 (75) .61
Relapse 0 (0) 1 (13) .29
30-d survival 18 (90) 7 (87) .99
1-y survival 17 (85) 7 (87) .99
Primary cause of death
 Nocardia infection 1 (5) 0 (0) .99
 Cancer 1 (5) 1 (12) .50
 Pulmonary embolism 1 (5) 0 (0) .99